Distribuzione geografica
Continente #
NA - Nord America 3556
EU - Europa 2449
AS - Asia 455
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
OC - Oceania 1
Totale 6475
Nazione #
US - Stati Uniti d'America 3553
IT - Italia 1143
FI - Finlandia 411
UA - Ucraina 349
CN - Cina 344
IE - Irlanda 123
DE - Germania 97
SE - Svezia 71
GB - Regno Unito 67
FR - Francia 62
RU - Federazione Russa 49
TR - Turchia 42
IR - Iran 25
RO - Romania 21
IN - India 20
BE - Belgio 19
BG - Bulgaria 10
KR - Corea 10
CH - Svizzera 8
AT - Austria 5
EU - Europa 5
MY - Malesia 5
NL - Olanda 5
TN - Tunisia 4
LB - Libano 3
MT - Malta 3
PE - Perù 3
SG - Singapore 3
CZ - Repubblica Ceca 2
MX - Messico 2
AU - Australia 1
BR - Brasile 1
CA - Canada 1
ES - Italia 1
GH - Ghana 1
GR - Grecia 1
JP - Giappone 1
NO - Norvegia 1
PL - Polonia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 6475
Città #
Fairfield 535
Woodbridge 320
Houston 295
Ann Arbor 289
Wilmington 265
Ashburn 224
Chandler 208
Palermo 206
Seattle 199
Jacksonville 196
Cambridge 187
Medford 125
Dublin 118
Nanjing 89
Princeton 77
Tulsa 52
Boardman 50
Altamura 49
San Diego 46
Dearborn 42
Lawrence 38
Beijing 37
Milan 31
Hebei 30
Shenyang 27
Izmir 26
Nanchang 23
Jinan 20
Napoli 20
Bremen 19
Rome 19
Changsha 18
Falls Church 18
Brussels 17
Jiaxing 15
Ningbo 15
Verona 14
Auburn Hills 13
Kumar 11
Bologna 10
Saint Petersburg 10
San Mateo 10
San Paolo di Civitate 10
Seongnam 10
Kunming 9
Los Angeles 9
Salerno 9
Sofia 9
Zhengzhou 9
Capaci 7
Redwood City 7
Sanayi 7
Tianjin 7
Catania 6
Durham 6
Hangzhou 6
Norwalk 6
Renton 6
San Giuliano Milanese 6
Shanghai 6
Taizhou 6
Tehran 6
Atlanta 5
Aversa 5
Haikou 5
Isfahan 5
Orange 5
Siena 5
Taiyuan 5
Florence 4
Moscow 4
Phoenix 4
Pisa 4
Agrigento 3
Busto Arsizio 3
Caserta 3
Düsseldorf 3
Foggia 3
Kuantan 3
Lima 3
Messina 3
Milpitas 3
Mountain View 3
Olgiate Olona 3
Recanati 3
Redmond 3
Reggio Calabria 3
Santa Maria A Monte 3
Turin 3
Viagrande 3
Alcamo 2
Amandola 2
Andover 2
Aragona 2
Baotou 2
Belmonte Mezzagno 2
Brescia 2
Caltanissetta 2
Campi Bisenzio 2
Candiolo 2
Totale 4282
Nome #
Curva da carico orale di metionina nella valutazione di pazienti affetti da patologia trombotica 477
Chemical and pharmaceutical evaluation of the relationship between triazole linkers and pore size on cyclodextrin–calixarene nanosponges used as carriers for natural drugs 164
Chemical Composition, In Vitro Antitumor and Pro-Oxidant Activities of Glandora rosmarinifolia (Boraginaceae) Essential Oil 162
Essential oil of Cyphostemma juttae (Vitaceae): chemical composition and antitumor mechanism in triple negative breast cancer cells 160
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 152
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell 147
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 141
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels 140
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 138
Analisi dei polimorfismi dei geni codificanti per l’enzima UDP-glucuronosiltrasferasi (UGT) e per l’enzima diidropirimidina deidrogenasi (DPD), correlati a maggiore tossicità in seguito a trattamento, rispettivamente, con Irinotecano e con 5-Fluorouracile in soggetti con tumore colon rettale (CRC) 137
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 134
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 132
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells 126
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 125
Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models 118
Unusual high dose of tacrolimus in liver transplant patient, a case report. 115
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. 113
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 110
NF-kB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers 104
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients 102
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. 99
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved? 99
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement 99
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 99
Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines 98
Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the HA22T/VGH model Overt hepatocellular carcinoma. 93
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis. 90
Effetti della curcumina e di suoi analoghi modificati al frammento beta-dichetone in cellule tumorali multifarmacoresistenti. 89
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 87
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 85
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma 84
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 83
Significance of autologous interleukin 6 production in the HA22T/VGH model of hepatocellular carcinoma 83
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 81
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View 77
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 76
Potential role of the natural multi-targeted agent curcumin in the treatment of oral diseases. 72
Plasma omocysteine levels in patients with chronic renal failure 71
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 70
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 69
null 67
Plasma homocysteine levels in patients with chronic renal failure. 66
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 66
Plant polyphenols as possible lead compound against hormone-independent multidrug resistant breast cancer. 63
Evaluations and new relationships between renal failure and homocysteine plasma levels in patients with chronic renal failure 63
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production 62
The antitumor activities of curcumin and of its novel isoxazole analogue MR 39 are not hampered by the multidrug resistant condition of tumor cells expressing both P-glycoprotein and different inhibitory of apoptosis proteins 59
“Antitumor and molecular effects of curcumin and of its isoxazole analogue on multidrug resistant breast cancer cells. New perspectives in tumor theraphy: molecular aspects, 2006”. 58
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression. 57
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production. 57
Effetti della curcumina e del suo derivato isossazolico in modelli di neoplasia multifarmacoresistente 55
Significance of Autologous Interleukin-6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma 55
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 53
Plasma homocysteine levels in patients with chronic renal failure 52
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 52
Effects of curcumin and related analogues on tumor cell lines expressing multiple mechanisms of drug resistance 51
Evaluation of patients with thrombotic stroke by methionine loading oral curve 51
Antitumor effects of the grape stilbenes resveratrol and piceatannol on multidrug and apoptosis resistant HL60 leukemia cells" 50
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 50
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 49
Le attività antitumorali della curcumina e del suo più potente analogo isossazolico non sono compromesse dal pattern di espressione genica della variante MDR della linea di carcinoma mammario MCF-7 47
Evaluations and new relationship between renal failure and homocysteine plasma levels in patients with chronic renal failure. 46
Design and synthesis of hybrid drugs based on curcumin scaffold 42
Effects of the dietary polyphenols resveratrol and curcumin on the prevention and treatment of cancer. 41
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 40
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 38
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 37
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 36
NF-κB is a potential pharmacological target in triple negative breast cancers. 35
Expression of a specific Thymidylate synthase polimorfic allele in metastatic colorectal patients is regulated by Myeloid Zinc Finger 1. 33
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It 32
Meccanismi antitumorali degli oli essenziali estratti da piante succulente in un modello di leucemia mielocitica acuta multifarmacoresistente 25
MDA-9/Syntenin-NF-κB-RKIP loop in triple negative breast cancers (TNBC) and human liver carcinoma 24
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 14
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia 9
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma 7
Totale 6774
Categoria #
all - tutte 9993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9993

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018390 0000 0112 10153 20433922
2018/2019648 42272611 2064 7815 3151137146
2019/20201768 23764107180 175221 190124 1769711978
2020/20211021 409444114 7853 9282 1326613096
2021/20221095 652213232 5432 6645 9818361206
2022/2023573 12916016134 1340 00 0000
Totale 6774